Cognigenics
PrivateLast Round
Accelerator
Feb 21, 2025
Total Funding Raised
$2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cognigenics operates in Healthcare & Life Sciences and is based in Stuart, Florida. Its latest recorded funding round was an Accelerator round in February 2025.
Cognigenics is a biotechnology company that develops RNA-based gene therapies targeting memory loss, cognitive decline, anxiety, and other neurocognitive and neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cognigenics Comparables
Compare Cognigenics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Switch Therapeutics | 78% | |
| Avast Therapeutics | 76% | |
| Aerska | 74% |
For institutional investors. Book with your work email.
Cognigenics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 21, 2025 | ||||
| Pre Seed | Jun 13, 2022 | ||||
| Angel | Feb 11, 2021 |
For institutional investors. Book with your work email.
Cognigenics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kilowatt Capital | Pre Seed |
| Arben Ventures | Seed, Pre Seed |
| Lionheart Ventures | Seed, Pre Seed |
| One Mind | Seed, Pre Seed, Accelerator |
| Fifth Street Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 105% MoM, reaching 3K.
- Feb 21, 2025
$100K raised from One Mind.
For institutional investors. Book with your work email.
Cognigenics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cognigenics's valuation, stock price, and market status.
Is Cognigenics a public or private company?
Cognigenics is a private company.
What is the current stock price of Cognigenics?
Cognigenics is a private company, so its shares have no public market price. Caplight tracks Cognigenics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cognigenics worth (valuation)?
Valuation information for Cognigenics is not publicly available.
Can I buy Cognigenics stock?
Cognigenics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cognigenics's last funding round?
Cognigenics's most recent funding round was Accelerator on February 21, 2025.
Who are the main investors in Cognigenics?
Key investors in Cognigenics include Kilowatt Capital, Arben Ventures, Lionheart Ventures, One Mind, Fifth Street Ventures.
Will Cognigenics IPO soon?
No public IPO plans have been announced for Cognigenics.
How can I track Cognigenics secondary market activity?
Caplight tracks bids, offers, and trades in Cognigenics's shares on secondary markets.